Market Announcement
9 July 2018
Benitec Biopharma Limited - Trading Halt
Description
The securities of Benitec Biopharma Limited (the 'Company') will be placed in trading halt at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 11 July 2018 or when the announcement is released to the market.
Security Code:
BLT
Issued by
Johanna O'Shea
Senior Adviser, Listings Compliance (Sydney)
9 July 2018
Market Announcement 1/1
ASX Limited
ASX Customer Service Centre 131 279 | asx.com.au
9 July 2018
Johanna O'Shea
ASX Compliance Pty Ltd 20 Bridge Street Sydney NSW 2000
By e-mail:tradinghaltssydney@asx.com.au
Dear Ms O'Shea
Request for Trading Halt
In accordance with ASX Listing Rule 17.1, Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) (Benitec) requests a trading halt of its securities, effective immediately.
For the purposes of the trading halt, Benitec provides the following information:
(a) Benitec is seeking the trading halt as it expects to make an announcement to the ASX in connection with a significant transaction;
(b) Benitec requests the trading halt be put in place until the earlier of the commencement of trading on Tuesday, 10 July 2018, or when an announcement is released to the market; and
(c)Benitec is not aware of any reason why the trading halt should not be granted or of any other information necessary to inform the market about the trading halt.
Should you have any queries in relation to this trading halt request, please do not hesitate to contact me.
Yours faithfully
Oliver Kidd Company Secretary
Attachments
- Original document
- Permalink
Disclaimer
Benitec Biopharma Ltd. published this content on 09 July 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 09 July 2018 00:23:05 UTC